Top

Published in:

01-03-2016 | Commentary

Gastrointestinal autonomic neuropathy in diabetes: the unattended borderline between diabetology and gastroenterology

Authors: Péter Kempler, Tamás Várkonyi, Anna E. Körei, Viktor J. Horváth

Published in: Diabetologia | Issue 3/2016

Excerpt

‘Autonomic dysfunction is often perceived as a black box of nebulous disorders, often not easily differentiated from variants of normality’ [1]. On the one hand, this sentence is still absolutely valid: most consequences of autonomic neuropathy are mild and silent. However, on the other hand, at the tip of the iceberg, there are very severe manifestations of autonomic dysfunction, such as sudden death and gastroparesis. …

Narkiewicz K, Somers VK (1998) Chronic orthostatic intolerance: part of a spectrum of dysfunction in orthostatic cardiovascular homeostasis? Circulation 98:2105–2107CrossRefPubMed

Kempler P, Ameranco G, Freeman R et al (2011) Gastrointestinal autonomic neuropathy, erectile-, bladder and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis and management. Diabetes Metab Res Rev 27:665–677CrossRefPubMed

Azpiroz F, Malagelada C (2015) Diabetic neuropathy in the gut: pathogenesis and diagnosis. Diabetologia. doi:10.1007/s00125-015-3831-1

Intagliata N, Koch KL (2007) Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment. Curr Gastroenterol Rep 9:270–279CrossRefPubMed

Izbéki F, Rosztóczy A, Várkonyi T, Wittmann T (2012) The clinical picture, diagnosis and therapy of gastrointestinal autonomic neuropathy. In: Kempler P, Várkonyi T (eds) Neuropathies. A global clinical guide. Zafír Press, Budapest, pp 131–150

Horváth V, Izbéki F, Cs L, Kempler P, Várkonyi T (2014) Diabetic gastroparesis: functional/morphologic background, diagnosis and treatment options. Curr Diab Rep 14:527CrossRefPubMed

Horowitz M, Jones KL, Rayner CK, Read NW (2006) ‘Gastric’ hypoglycaemia: an important concept in diabetes management. Neurogastroenterol Motil 18:405–407CrossRefPubMed

Wackers FJ, Young LH, Inzucchi SE et al (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954–1961CrossRefPubMed

Spallone V, Ziegler D, Freeman R et al (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27:639–653CrossRefPubMed

10.

Phillips LK, Rayner CK, Jones KL, Horowitz M (2006) An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep 6:417–423CrossRefPubMed

11.

Barkai L, Kempler P, Vámosi I, Lukács K, Marton A, Keresztes K (1998) Peripheral sensory nerve dysfunction in children and adolescents with type 1 diabetes mellitus. Diabetic Med 15:228–233CrossRefPubMed

12.

Horváth V, Putz Z, Izbéki F et al (2015) Diabetes-related dysfunction of the small intestine and the colon: focus on motility. Curr Diab Rep 15:94. doi:10.1007/s11892-015-0672-8 CrossRefPubMed

13.

Deloose E, Janssen P, Depoortere I, Tack J (2012) The migrating motor complex: control mechanisms and its role in health and disease. Nat Rev Gastroenterol Hepatol 9:271–285CrossRefPubMed

14.

Törnblom H (2015) Treatment of gastrointestinal autonomic neuropathy. Diabetologia. doi:10.1007/s00125-015-3828-9

Title: Gastrointestinal autonomic neuropathy in diabetes: the unattended borderline between diabetology and gastroenterology
Authors: Péter Kempler
Tamás Várkonyi
Anna E. Körei
Viktor J. Horváth
Publication date: 01-03-2016
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 3/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-015-3826-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Gastrointestinal autonomic neuropathy in diabetes: the unattended borderline between diabetology and gastroenterology

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2016

Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes

LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes

Blood-based signatures in type 1 diabetes

Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial

Assessment of established HDL-C loci for association with HDL-C levels and type 2 diabetes in Pima Indians

Muscle-specific inflammation induced by MCP-1 overexpression does not affect whole-body insulin sensitivity in mice

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page